loading

Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
10.62%
2.0287
2.2697 2.1492 2.7818 2.8216
Operating Income/Loss
10.62%
-2.0287
-2.2697 -2.1765 - -
Income/Loss From Continuing Operations Before Tax
11.28%
-1.9928
-2.2463 -2.1492 -2.7818 -2.8216
Income/Loss From Continuing Operations After Tax
11.28%
-1.9928
-2.2463 -2.1492 -2.7818 -2.8216
Net Income/Loss
11.28%
-1.9928
-2.2463 -2.1492 -2.7818 -2.8216
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
36.59%
1.6258
1.1903 20.04 0.2556 16.36
Diluted Average Shares
36.59%
1.6258
1.1903 20.04 0.2556 16.36
Basic Earnings Per Share
34.92%
-1.23
-1.89 -0.11 -0.16 -0.17
Diluted Earnings Per Share
34.92%
-1.23
-1.89 -0.11 -0.16 -0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):